A single overnight infusion of TAK-925, a selective orexin 2 receptor agonist, reduces obstructive sleep apnea severity

Osman, A.; Mukherjee, S.; Loffler, K.; Altree, T.; Proctor, S.; Adams, R.; Nguyen, P.; O'Reilly, C.; Naik, G.; Fauska, J.; Yao, B.; Toson, B.; Cai, A.; Buhl, D.; Naylor, M.; Olsson, T.; Meyer, S.; Rosen, L.; Eckert, D.

doi:10.1016/j.sleep.2023.11.879

A single overnight infusion of TAK-925, a selective orexin 2 receptor agonist, reduces obstructive sleep apnea severity

Date

2024

Authors

Osman, A.

Mukherjee, S.

Loffler, K.

Altree, T.

Proctor, S.

Adams, R.

Nguyen, P.

O'Reilly, C.

Naik, G.

Fauska, J.

Type:

Conference item

Citation

Abstracts of the 17th World Sleep Congress, as published in Sleep Medicine, 2024, vol.115, iss.Suppl. 1, pp.326-326

Statement of Responsibility

A. Osman, S. Mukherjee, K. Loffler, T. Altree, S. Proctor, R. Adams, P. Nguyen, C. O, Reilly, G. Naik, J. Fauska, B. Yao, B. Toson, A. Cai, D. Buhl, M. Naylor, T. Olsson, S. Meyer, L. Rosen, D. Eckert

Conference Name

17th World Sleep Congress (20 Oct 2023 - 25 Oct 2023 : Rio de Janeiro, Brazil)

DOI

10.1016/j.sleep.2023.11.879

Rights

Grant ID

http://purl.org/au-research/grants/nhmrc/1196261

Published Version

https://www.sciencedirect.com/journal/sleep-medicine/vol/115/suppl/S1

Persistent link to this record

https://hdl.handle.net/2440/148020

Full item page

A single overnight infusion of TAK-925, a selective orexin 2 receptor agonist, reduces obstructive sleep apnea severity

Date

Authors

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Citation

Statement of Responsibility

Conference Name

DOI

Abstract

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

License

Grant ID

Published Version

Call number

Persistent link to this record